Drug
Ism9528
Ism9528: highest development phase Phase 1, developed by InSilico Medicine Hong Kong Limited. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- InSilico Medicine Hong Kong Limited
Trials
| Drug | Phase | Indication |
|---|---|---|
| ISM9528 capsules NCT07932041 | Phase 1 |
Latest
No recent events.
Follow Ism9528 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.